What is the Projected CAGR value of the Oral Anti Diabetes Drugs Market?
The Oral Anti Diabetes Drugs Market is expected to grow at a high CAGR of 8.0% from 2023 to 2030.
Who are the Key Players of Oral Anti Diabetes Drugs Market ?
The major global players in the market include Glenmark Pharma, Abbott, Biocon, Sanofi S.A., Sunpharma, Novartis, Novo Nordisk, Merck, GlaxoSmithKline, and Bristol-Myers Squibb among others.
Which region controlled the global market during 2023-2030?
North America region Controls the Oral Anti Diabetes Drugs Market during 2023-2030.
What are the drivers of the global oral anti-diabetic drug market?
The increasing prevalence of diabetes and the growing aging population are the two main drivers of the global oral anti-diabetic drug market growth.